|ATA||Beijing, Beijing, China|
|Brinson Partners||Chicago, Illinois, United States|
|CLP Data Services||-|
|Hercules Capital, Inc.||California, Palo Alto, United States|
|Jennison Associates||New York, New York, United States|
|Long Pinxi Capital||-|
|Maven 11 Capital||Amsterdam, Noord-Holland, The Netherlands|
|Monroe-Brown Biomedical Seed Fund||-|
|Novelion Therapeutics||British Columbia, Canada, Vancouver|
|Shalamuka Capital||Gauteng, NA - South Africa, South Africa|
|The TCW Group||California, Los Angeles, United States|
|TrueBridge Capital Partners||Chapel Hill, North Carolina, United States|
|Unilazer Ventures||India, Maharashtra, Mumbai|
|Zimi Fund||China, Shanghai|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.